SDC1 and medical procedure: Under ischemic and hypoxic conditions (transient middle cerebral artery occlusion (t-MACO) model), the glycocalyx (GCX) undergoes enzymatic degradation, facilitating the interaction between syndecan-1 and Src by enhancing the binding of phosphorylated syndecan-1 to the Src SH2 domain.